FDA Class II Device Recall: GEM Premier 5000
Summary
The FDA has initiated a Class II device recall for Instrumentation Laboratory's GEM Premier 5000, Part No. 00055415008, due to Process Control Solution Not Detected (PCSND) errors. The recall affects worldwide distribution, including the US.
What changed
The FDA has classified a recall of the GEM Premier 5000 device (Part No. 00055415008) as Class II, indicating that use of or exposure to a defective product may cause adverse health consequences that are temporary or medically reversible. The issue stems from confirmed customer complaints of Process Control Solution Not Detected (PCSND) errors during the warm-up phase of the GEM PAK cartridges, which can lead to GEM PAK ejection.
This recall impacts worldwide distribution, including the United States and several other countries. Manufacturers and healthcare providers utilizing this device should be aware of this recall and consult Instrumentation Laboratory's specific instructions for managing the affected product. While the document does not specify a compliance deadline, the ongoing nature of the recall implies immediate attention is required for affected units and inventory.
What to do next
- Review Instrumentation Laboratory's recall instructions for GEM Premier 5000
- Identify and manage affected GEM PAK cartridges and devices
- Report any adverse events related to this issue to the FDA
Source document (simplified)
Instrumentation Laboratory
Device Recalls (Class II)
← All Device Recalls (Class II) Class II Z-1534-2026 · 20260318 · Ongoing
Product
GEM Premier 5000; Part No. 00055415008.
Reason for Recall
Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of ...
Distribution
Worldwide distribution - US Nationwide and the countries of Argentina, Austria, Australia, Belgium, Bulgaria, Brazil, Belarus, Switzerland, Canada,...
Source: openFDA Enforcement API
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when FDA: Device Recalls Class II publishes new changes.